78 related articles for article (PubMed ID: 8135498)
21. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
22. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management.
Lynch HT; Riley BD; Weissman SM; Coronel SM; Kinarsky Y; Lynch JF; Shaw TG; Rubinstein WS
Cancer; 2004 Jan; 100(1):53-64. PubMed ID: 14692024
[TBL] [Abstract][Full Text] [Related]
23. Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review.
Johnson PM; Gallinger S; McLeod RS
Dis Colon Rectum; 2006 Jan; 49(1):80-93; discussion 94-5. PubMed ID: 16284887
[TBL] [Abstract][Full Text] [Related]
24. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
Hadley DW; Jenkins JF; Dimond E; de Carvalho M; Kirsch I; Palmer CG
J Clin Oncol; 2004 Jan; 22(1):39-44. PubMed ID: 14701766
[TBL] [Abstract][Full Text] [Related]
25. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
Brown GJ; St John DJ; Macrae FA; Aittomäki K
Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
[TBL] [Abstract][Full Text] [Related]
26. The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up.
Thiis-Evensen E; Hoff GS; Sauar J; Majak BM; Vatn MH
Am J Gastroenterol; 2001 Jun; 96(6):1901-7. PubMed ID: 11419846
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of recognition of the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectal cancer.
Jablonská M; Rezníková L; Kotrlík J; Svitavský M; Miková M; Tabach J
Sb Lek; 1995; 96(3):275-82. PubMed ID: 8718819
[TBL] [Abstract][Full Text] [Related]
28. Surveillance in Lynch syndrome: how aggressive?
Lanspa SJ; Jenkins JX; Cavalieri RJ; Smyrk TC; Watson P; Lynch J; Lynch HT
Am J Gastroenterol; 1994 Nov; 89(11):1978-80. PubMed ID: 7942721
[TBL] [Abstract][Full Text] [Related]
29. First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer.
Lynch KL; Ahnen DJ; Byers T; Weiss DG; Lieberman DA
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):96-102. PubMed ID: 15017501
[TBL] [Abstract][Full Text] [Related]
30. Colonoscopy for screening and follow up of patients with a family history of colorectal cancer.
Tytherleigh MG; Ng VV; Mathew LO; Banerjee T; Menon KV; Mee AS; Farouk R
Colorectal Dis; 2008 Jun; 10(5):506-11. PubMed ID: 18318755
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
[TBL] [Abstract][Full Text] [Related]
32. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
[TBL] [Abstract][Full Text] [Related]
33. Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members.
Katballe N; Juul S; Christensen M; Ørntoft TF; Wikman FP; Laurberg S
Br J Surg; 2001 Sep; 88(9):1228-33. PubMed ID: 11531872
[TBL] [Abstract][Full Text] [Related]
34. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
[TBL] [Abstract][Full Text] [Related]
35. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer.
Renkonen-Sinisalo L; Aarnio M; Mecklin JP; Järvinen HJ
Cancer Detect Prev; 2000; 24(2):137-42. PubMed ID: 10917133
[TBL] [Abstract][Full Text] [Related]
36. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.
Park YJ; Shin KH; Park JG
Clin Cancer Res; 2000 Aug; 6(8):2994-8. PubMed ID: 10955776
[TBL] [Abstract][Full Text] [Related]
37. Pathology of hereditary non-polyposis colorectal cancer.
Jass JR; Smyrk TC; Stewart SM; Lane MR; Lanspa SJ; Lynch HT
Anticancer Res; 1994; 14(4B):1631-4. PubMed ID: 7979198
[TBL] [Abstract][Full Text] [Related]
38. Colorectal adenomas in the Lynch syndromes. Results of a colonoscopy screening program.
Lanspa SJ; Lynch HT; Smyrk TC; Strayhorn P; Watson P; Lynch JF; Jenkins JX; Appelman HD
Gastroenterology; 1990 May; 98(5 Pt 1):1117-22. PubMed ID: 2323504
[TBL] [Abstract][Full Text] [Related]
39. Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC).
Stanley AJ; Gaff CL; Aittomäki AK; Fabre LC; Macrae FA; St John J
Med J Aust; 2000 Apr; 172(7):313-6. PubMed ID: 10844916
[TBL] [Abstract][Full Text] [Related]
40. Natural history of at-risk Lynch syndrome family members with respect to adenomas.
Lanspa SJ; Jenkins JX; Watson P; Smyrk TC; Cavalieri RJ; Lynch JF; Lynch HT
Nebr Med J; 1992 Nov; 77(11):310-3. PubMed ID: 1461324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
